HomeZENTEC › Filing
🔔 Get instant alerts when ZENTEC files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 26 Jul 2026, 23:56 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 revenue at ₹141.64 Cr reflects early execution stage; weighted to Q2/Q3 FY27 - Consolidated order book ₹1,239.02 Cr as of June 30, 2026; additional ₹177.50 Cr order in July 2026 - New product launches: AI-powered anti-drone system, Hyperstrike interceptor drone, Zen Vrishab UGV, Integrated Smart Border Suite - Leadership in Army and Navy training; Air Force entry expected with OEM partnerships in FY27 - Government procurement prioritizes counter-drone and unmanned platforms; strong Buy Indian-IDDM emphasis - Q1FY27 EBITDA ₹57.88 Cr; PAT ₹34.46 Cr; EBITDA margin 40.9%, operational EBITDA margin 27.3% - Order book execution cycle ~12 months; new orders till Q2 FY27 partially executed by Q4 FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ZENTEC — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ZENTEC to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Zen Technologies Limited

Important. The summary above is generated automatically from Zen Technologies Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.